Loncastuximab Tesirine in WM

NCT05190705 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Waldenstrom Macroglobulinemia

Interventions

DRUG: Loncastuximab Tesirine
DRUG: Dexamethasone

Sponsor

Shayna Sarosiek, MD

Collaborators

[object Object]